Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2003, p. 2649-2654, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2649-2654.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Reduced Release of Pneumolysin by Streptococcus pneumoniae In Vitro and In Vivo after Treatment with Nonbacteriolytic Antibiotics in Comparison to Ceftriaxone
Annette Spreer,1 Holger Kerstan,1 Tobias Böttcher,1 Joachim Gerber,1 Alexander Siemer,2,
Gregor Zysk,3 Timothy J. Mitchell,4 Helmut Eiffert,5 and Roland Nau1*
Departments of Neurology,1
Medical Statistics,2
Bacteriology, University of Göttingen, Göttingen,5
Department of Medical Microbiology and Virology, University of Düsseldorf, Düsseldorf, Germany,3
Division of Infection and Immunity, University of Glasgow, Glasgow, Scotland4
Received 26 August 2002/
Returned for modification 14 February 2003/
Accepted 7 May 2003
Pneumolysin, a virulence factor of Streptococcus pneumoniae with cytotoxic and proinflammatory activities, occurs at concentrations from 0.85 to 180 ng/ml in cerebrospinal fluid (CSF) of meningitis patients. In pneumococcal cultures and in a rabbit meningitis model, the concentrations of pneumolysin in supernatant and CSF were lower after addition of nonbacteriolytic bactericidal antibiotics (rifampin and clindamycin) than after incubation with ceftriaxone.
* Corresponding author. Mailing address: Department of Neurology, University Hospital, Robert-Koch-Str. 40, 37075 Göttingen, Germany. Phone: 49-551-398455. Fax: 49-551-398405. E-mail:
rnau{at}gwdg.de.
Present address: Boehringer Ingelheim, Biberach an der Ries, Germany.
Antimicrobial Agents and Chemotherapy, August 2003, p. 2649-2654, Vol. 47, No. 8
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.8.2649-2654.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Cockeran, R., Mitchell, T. J., Feldman, C., Anderson, R.
(2009). Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils. Eur Respir J
34: 1167-1170
[Abstract]
[Full Text]
-
Calbo, E., Alsina, M., Rodriguez-Carballeira, M., Lite, J., Garau, J.
(2008). Systemic Expression of Cytokine Production in Patients with Severe Pneumococcal Pneumonia: Effects of Treatment with a {beta}-Lactam versus a Fluoroquinolone. Antimicrob. Agents Chemother.
52: 2395-2402
[Abstract]
[Full Text]
-
Anderson, R., Steel, H. C., Cockeran, R., Smith, A. M., von Gottberg, A., de Gouveia, L., Brink, A., Klugman, K. P., Mitchell, T. J., Feldman, C.
(2007). Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother
59: 224-229
[Abstract]
[Full Text]
-
Herrmann, I., Kellert, M., Spreer, A., Gerber, J., Eiffert, H., Prinz, M., Nau, R.
(2007). Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice. J Antimicrob Chemother
59: 74-79
[Abstract]
[Full Text]
-
Meli, D. N., Coimbra, R. S., Erhart, D. G., Loquet, G., Bellac, C. L., Tauber, M. G., Neumann, U., Leib, S. L.
(2006). Doxycycline Reduces Mortality and Injury to the Brain and Cochlea in Experimental Pneumococcal Meningitis. Infect. Immun.
74: 3890-3896
[Abstract]
[Full Text]
-
Fukuda, Y., Yanagihara, K., Higashiyama, Y., Miyazaki, Y., Hirakata, Y., Mukae, H., Tomono, K., Mizuta, Y., Tsukamoto, K., Kohno, S.
(2006). Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae. Eur Respir J
27: 1020-1025
[Abstract]
[Full Text]
-
Buckingham, S. C., McCullers, J. A., Lujan-Zilbermann, J., Knapp, K. M., Orman, K. L., English, B. K.
(2006). Early Vancomycin Therapy and Adverse Outcomes in Children With Pneumococcal Meningitis. Pediatrics
117: 1688-1694
[Abstract]
[Full Text]
-
Yuste, J., Botto, M., Paton, J. C., Holden, D. W., Brown, J. S.
(2005). Additive Inhibition of Complement Deposition by Pneumolysin and PspA Facilitates Streptococcus pneumoniae Septicemia. J. Immunol.
175: 1813-1819
[Abstract]
[Full Text]
-
Athamna, A., Athamna, M., Nura, A., Shlyakov, E., Bast, D. J., Farrell, D., Rubinstein, E.
(2005). Is In Vitro Antibiotic Combination More Effective than Single-Drug Therapy against Anthrax?. Antimicrob. Agents Chemother.
49: 1323-1325
[Abstract]
[Full Text]
-
Hirst, R. A., Mohammed, B. J., Mitchell, T. J., Andrew, P. W., O'Callaghan, C.
(2004). Streptococcus pneumoniae-Induced Inhibition of Rat Ependymal Cilia Is Attenuated by Antipneumolysin Antibody. Infect. Immun.
72: 6694-6698
[Abstract]
[Full Text]
-
Schmeck, B., Gross, R., N'Guessan, P. D., Hocke, A. C., Hammerschmidt, S., Mitchell, T. J., Rosseau, S., Suttorp, N., Hippenstiel, S.
(2004). Streptococcus pneumoniae-Induced Caspase 6-Dependent Apoptosis in Lung Epithelium. Infect. Immun.
72: 4940-4947
[Abstract]
[Full Text]
-
Spreer, A., Lis, A., Gerber, J., Reinert, R. R., Eiffert, H., Nau, R.
(2004). Differences in Clinical Manifestation of Streptococcus pneumoniae Infection Are Not Correlated with In Vitro Production and Release of the Virulence Factors Pneumolysin and Lipoteichoic and Teichoic Acids. J. Clin. Microbiol.
42: 3342-3345
[Abstract]
[Full Text]